Cargando…
Etoricoxib-Cannabidiol Combo: Potential Role in Glioblastoma Treatment and Development of PLGA-Based Nanoparticles
Background: Glioblastoma (GBM) is the most frequently occurring primary malignant central nervous system tumor, with a poor prognosis and median survival below two years. Administration of a combination of non-steroidal anti-inflammatory drugs and natural compounds that exhibit a curative or prophyl...
Autores principales: | Kuźmińska, Joanna, Sobczak, Agnieszka, Majchrzak-Celińska, Aleksandra, Żółnowska, Izabela, Gostyńska, Aleksandra, Jadach, Barbara, Krajka-Kuźniak, Violetta, Jelińska, Anna, Stawny, Maciej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459258/ https://www.ncbi.nlm.nih.gov/pubmed/37631318 http://dx.doi.org/10.3390/pharmaceutics15082104 |
Ejemplares similares
-
Honokiol-Loaded Nanoemulsion for Glioblastoma Treatment: Statistical Optimization, Physicochemical Characterization, and an In Vitro Toxicity Assay
por: Gostyńska, Aleksandra, et al.
Publicado: (2023) -
The Development of Magnolol-Loaded Intravenous Emulsion with Low Hepatotoxic Potential
por: Gostyńska, Aleksandra, et al.
Publicado: (2023) -
Cannabidiol and Its Combinations with Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis and Inhibit Activation of NF-κB Signaling in Vulvar Squamous Cell Carcinoma
por: Krajka-Kuźniak, Violetta, et al.
Publicado: (2022) -
Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma
por: Piwowarczyk, Ludwika, et al.
Publicado: (2022) -
COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells
por: Majchrzak-Celińska, Aleksandra, et al.
Publicado: (2021)